Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2022 ∙ Chu, D. K. Abrams, E. M. Golden, D. B. K. Blumenthal, K. G. Wolfson, A. R. Stone, C. A., Jr. Krantz, M. S. Shaker, M. Greenhawt, M.
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis
Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Kechagias, K. S. Kalliala, I. Bowden, S. J. Athanasiou, A. Paraskevaidi, M. Paraskevaidis, E. Dillner, J. Nieminen, P. Strander, B. Sasieni, P. Veroniki, A. A. Kyrgiou, M.
Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis
All age groups Human papillomavirus (HPV) Efficacy/effectiveness
Rating:
Low
2022 ∙ Zhang, X. Xu, X. F. Jin, J.
Rotavirus vaccination and the risk of type 1 diabetes and celiac disease: A systematic review and meta-analysis
Newborn Children Adolescents Rotavirus Safety
Rating:
Critically low
2022 ∙ SeyedAlinaghi, S. Karimi, A. Pashaei, Z. Afzalian, A. Mirzapour, P. Ghorbanzadeh, K. Ghasemzadeh, A. Dashti, M. Nazarian, N. Vahedi, F. Tantuoyir, M. M. Shamsabadi, A. Dadras, O. Mehraeen, E.
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Dadras, O. Mehraeen, E. Karimi, A. Tantuoyir, M. M. Afzalian, A. Nazarian, N. Mojdeganlou, H. Mirzapour, P. Shamsabadi, A. Dashti, M. Ghasemzadeh, A. Vahedi, F. Shobeiri, P. Pashaei, Z. SeyedAlinaghi, S.
Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax;a Systematic Review
All age groups COVID-19 Safety
Rating:
Critically low
2022 ∙ Mehta, N. Shah, S. Paudel, K. Chamlagain, R. Chhetri, S.
Safety and efficacy of coronavirus disease-19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review
Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Tian, F. Yang, R.
Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials
Newborn Children COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Lopez-Olivo, M. A. Valerio, V. Karpes Matusevich, A. R. Brizio, M. Kwok, M. Geng, Y. Suarez-Almazor, M. E. Colmegna, I.
Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis
All age groups Influenza Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Xu, W. Tang, J. Chen, C. Wang, C. Wen, W. Cheng, Y. Zhou, M. Wu, Q. Zhang, X. Feng, Z. Wang, M.
Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis
Children Adolescents COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Simayi, A. Zhu, L. Jin, H.
Safety and Immunogenicity of Pertussis Vaccine Immunization during Pregnancy: A Meta-Analysis of Randomized Clinical Trials
Pregnant women Pertussis Safety Efficacy/effectiveness
Rating:
Low
Loading...